Elections › Corporate Influence › PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

🏛️ PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

CORPORATE LOBBYING & ELECTION INFLUENCE PROFILE

$21.5M
Lobbying Spend
$2.2M
Campaign Spending
24
Lobbyists
1
Races Influenced
36
LDA Filings
Lobbying Issue Areas
🏥 Healthcare & Pharma💰 Finance & Banking🛡️ Defense & Security
Filing Quarters
first_quarterfourth_quartersecond_quarterthird_quarter
Specific Lobbying Issues
Pharmacy Benefit Managers (PBM) provisions to be included in potential congressional legislation, including but not limited to the Continuing Resolution; engagement with the Trump Administration, incl
Pharmacy Benefit Managers (PBM) provisions to be included in potential congressional legislation, including but not limited to the Continuing Resolution; engagement with the Trump Administration, incl
Pharmacy Benefit Managers (PBM) provisions to be included in potential congressional legislation, including but not limited to the Continuing Resolution; engagement with the Trump Administration, incl
issues related to healthcare and pharmaceuticals
issues related to healthcare and pharmaceuticals
Where the Money Is Going
Race Campaign $ Candidate(s)
GA-SEN
$2.2M
OSSOFF
Source: Senate LDA lobbying disclosures + FEC campaign finance data + USAspending.gov via Hammerhead Intelligence
Lobbying $ = annual reported federal lobbying expenditures (company-wide). Campaign $ = IE spending directed at candidates in specific races. Govt Contracts $ = federal awards from USAspending.gov.
Last updated: 2026-11-01